Clinical Trial Manager, Oncology at Eikon Therapeutics

Millbrae, California, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

BiopharmaceuticalIndustries

Requirements

Candidates must possess strong communication skills, be collaborative, agile, and detail-oriented trial leaders with global trial experience. A passion for operational excellence and advancing patient care is essential, along with the ability to work independently and as an engaged team member in a dynamic, fast-paced environment. A minimum of 3 days a week onsite presence in California, New York, or New Jersey offices is required.

Responsibilities

The Clinical Trial Manager will provide guidance and daily oversight for the in-house management of international clinical trials, ensuring high-quality data delivery on time and within budget. Responsibilities include developing and executing operational plans, collaborating with cross-functional teams, managing trial start-up activities, ensuring site initiation and monitoring, maintaining relationships with study site personnel, monitoring study progress, implementing corrective actions, ensuring regulatory compliance (ICH-GCP, FDA), collaborating with external vendors, and contributing to the development and review of study-related documents.

Skills

Clinical Trial Management

Regulatory Guidelines

Clinical Study Management

Global Clinical Trials

Communication

Leadership

Operational Excellence

Project Management

Eikon Therapeutics

Biotech startup developing innovative medicines

About Eikon Therapeutics

Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that aim to improve and extend life. A key feature of Eikon's approach is their proprietary single-molecule tracking (SMT) platform, which enables rapid visualization of protein movements in living cells. This technology, along with artificial intelligence and automation, allows for precise inventorying of molecular interactions. Eikon Therapeutics targets patients with serious diseases who need effective treatments, generating revenue through the development and commercialization of their therapies.

Hayward, CaliforniaHeadquarters

2019Year Founded

$750.8MTotal Funding

SERIES_CCompany Stage

AI & Machine Learning, BiotechnologyIndustries

201-500Employees

Benefits

401(k) Company Match

Medical (premiums covered by Eikon at 95%)

Dental Insurance

Vision Insurance

Mental Health Support

Unlimited Paid Time Off

Paid Holidays

Life Insurance

Enhanced Parental Leave

Daily subsidized lunch program

Risks

Competition from biotech unicorns like Abogen Biosciences is increasing.

Integrating new clinical-stage assets may delay drug development timelines.

Reliance on SMT technology risks obsolescence from emerging molecular biology technologies.

Differentiation

Eikon uses proprietary single-molecule tracking for real-time protein movement analysis.

The company integrates AI and automation for large-scale molecular interaction studies.

Eikon's diverse team combines expertise in science, engineering, and technology.

Upsides

Growing interest in SMT technology boosts Eikon's drug discovery potential.

Partnerships with AI firms enhance Eikon's drug candidate identification.

Rising demand for precision medicine aligns with Eikon's focus on dynamic biology.

Land your dream remote job 3x faster with AI

Try Jobo Free